<code id='DB466BA7EA'></code><style id='DB466BA7EA'></style>
    • <acronym id='DB466BA7EA'></acronym>
      <center id='DB466BA7EA'><center id='DB466BA7EA'><tfoot id='DB466BA7EA'></tfoot></center><abbr id='DB466BA7EA'><dir id='DB466BA7EA'><tfoot id='DB466BA7EA'></tfoot><noframes id='DB466BA7EA'>

    • <optgroup id='DB466BA7EA'><strike id='DB466BA7EA'><sup id='DB466BA7EA'></sup></strike><code id='DB466BA7EA'></code></optgroup>
        1. <b id='DB466BA7EA'><label id='DB466BA7EA'><select id='DB466BA7EA'><dt id='DB466BA7EA'><span id='DB466BA7EA'></span></dt></select></label></b><u id='DB466BA7EA'></u>
          <i id='DB466BA7EA'><strike id='DB466BA7EA'><tt id='DB466BA7EA'><pre id='DB466BA7EA'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:58651
          The U.S. Capitol reflection. -- health coverage from STAT
          Nathan Howard/Getty Images

          WASHINGTON — Around the country, statehouses from Harrisburg, Pa., to Tallahassee, Fla., are being flooded with tobacco industry lobbyists, according to a new report from the anti-smoking advocacy group Action on Smoking and Health. 

          There are now at least 950 lobbyists representing cigarette, vape, and snus companies in statehouses around the country, according to the latest edition of the group’s Tobacco Industry Lobbyist and Lobbying Firm Registration Tracker, which was released Thursday. The number of lobbying registrations tied to tobacco companies jumped over 10% from 2023 to 2024. 

          advertisement

          ASH’s overall tally, which is based on publicly available lobbying registration data, is likely an undercount because several states only require lobbying firms, not individual lobbyists, to register with the state. 

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          MassMutual is introducing free genetic testing for members
          MassMutual is introducing free genetic testing for members

          AdobeOneofthecountry’sbiggestlifeinsurersisventuringintogenetictesting,anareathat’shistoricallybeena

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          With competition flaring, obesity drug hits goal in liver disease study

          AdobeLONDON—AdrugindevelopmentasaweightlosstreatmentsucceededinaPhase2studyinaseriouslivercondition,